D-Cbl Binding to Drk Leads to Dose-Dependent Down-Regulation of EGFR Signaling and Increases Receptor-Ligand Endocytosis
2011
D-Cbl Binding to Drk Regulates EGFR Signaling
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Wang Pei-Yu, Pai Li-Mei
Primary Institution: Chang Gung University, Tao-Yuan, Taiwan
Hypothesis
How does D-CblL control EGFR signaling at the molecular level?
Conclusion
D-CblL down-regulates EGFR signaling through its interaction with Drk and promotes endocytosis of the ligand-receptor complex.
Supporting Evidence
- D-CblL promotes endocytosis of the ligand-receptor complex.
- Drk is essential for the dose-dependent regulation of EGFR signaling.
- Fusion proteins of D-CblL can effectively down-regulate EGFR signaling.
Takeaway
This study shows that a protein called D-CblL helps control a signaling process in cells that can lead to cancer if not regulated properly.
Methodology
The study used genetic assays and protein interaction analyses in Drosophila to investigate the role of D-CblL and Drk in EGFR signaling.
Limitations
The study primarily focuses on Drosophila, which may limit the applicability of findings to other organisms.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website